SARS-CoV-2: An Update on the Biological Interplay with the Human Host

Author:

Lippi Giuseppe1ORCID,Sanchis-Gomar Fabian2,Mattiuzzi Camilla3ORCID,Henry Brandon M.4

Affiliation:

1. Section of Clinical Biochemistry and School of Medicine, University of Verona, 37134 Verona, Italy

2. Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA

3. Medical Direction, Rovereto Hospital, Provincial Agency for Social and Sanitary Services (APSS), 38068 Rovereto, Italy

4. Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45201, USA

Abstract

Coronavirus Disease 2019 (COVID-19) is an infectious respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease, first identified in the Chinese city of Wuhan in November 2019, has since spread worldwide, is the latest human pandemic and has officially infected over 800 million people and has caused nearly seven million deaths to date. Although SARS-CoV-2 belongs to the large family of coronaviruses, it has some unique biological characteristics in its interplay with the human host. Therefore, this narrative review aims to provide an up-to-date overview of the structure of the virus, incubation and shedding in the human host, infectivity and biological evolution over time, as well as the main mechanisms for invading human host cells and replicating within. We also proffer that ongoing epidemiological surveillance of newly emerged variants must always be accompanied by biological studies aimed at deciphering new advantageous traits that may contribute to increasing virulence and pathogenicity, such that the most appropriate strategies for establishing a (relatively) safe coexistence with the human host can be implemented.

Publisher

MDPI AG

Subject

General Medicine

Reference85 articles.

1. Pandemics Throughout the History;Sampath;Cureus,2021

2. Uncontrolled confounding in COVID-19 epidemiology;Lippi;Diagnosis,2022

3. COVID-19: WHO declares end of global health emergency;Wise;BMJ,2023

4. World Health Organization (2023, September 10). WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/.

5. Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status—United States, April 2021–September 2022;Jones;Morb. Mortal. Wkly. Rep.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3